1 year return (CAGR)
100.58%
Halozyme Therapeutics Inc Exchange (NASDAQ, USD)
HALO
131.18
+1.15 (+0.88%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
55.56%
5 year return (CAGR)
27.57%
10 year return (CAGR)
30.28%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
14.89B
Price/Sales
8.95
Ent value
17.16B
Price/Book
103.72
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
36.00
PEG
-
Forward P/E
12.62
EPS growth
22.89%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 131.01 |
| Daily high | 132.55 |
| Daily low | 130.09 |
| Daily Volume | 1.87M |
| All-time high | 131.18 |
| 1y analyst estimate | 99.56 |
| Beta | 0.88 |
| EPS (TTM) | 3.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| HALO | S&P500 | |
| Current price drop from All-time high | -4.86% | -1.25% |
| Highest price drop | -74.26% | -56.47% |
| Date of highest drop | 4 Dec 2008 | 9 Mar 2009 |
| Avg drop from high | -31.39% | -10.65% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 1209 days | 1805 days |
News
